107332-84-3

Upstream product

• 107332-83-2 3-(2-bromoethoxy)phenol 
• 100-46-9 benzylamine 

Downstream Products

• 107332-79-6 N-benzyl-N-(2-m-hydroxyphenoxyethyl)-2-hydroxy-3-phenoxypropylamine 
• 107332-80-9 methyl 2-m-(2-[N-benzyl-(2-hydroxy-3-phenoxypropyl)amino]ethoxy)phenoxyacetate 
• 107332-82-1 {3-[2-(2-Hydroxy-3-phenoxy-propylamino)-ethoxy]-phenoxy}-acetic acid methyl ester 
• 140662-48-2 (3-{2-[3-(2-Fluoro-phenoxy)-2-hydroxy-propylamino]-ethoxy}-phenoxy)-acetic acid methyl ester 

Relevant academic research and scientific papers

Amide derivatives

The invention concerns novel phenoxyacetic acid amide derivatives of the formula I (and pharmaceutically acceptable salts thereof) in which R1 is hydrogen or fluoro, R2 is phenyl, cycloalkyl, alkyl or alkenyl as defined herein, and R3 is hydrogen, methyl or ethyl, or R2 and R3 together form polymethylene as defined herein. The invention also includes pharmaceutical compositions containing the amide derivatives, means for the manufacture of the said derivatives and for their use in the treatment of obesity and related conditions and/or in the manufacture of novel medicaments.

Phenyl ethers

The invention concerns a series of novel phenoxyacetic acid ethers (and pharmaceutically acceptable salts thereof) of the formula I in which R1 is H or F, R2 and R3 are H or (1-3C)alkyl, Z is CH2 OH or a group -